We use cookies to analyze site traffic and improve your experience.
By accepting, you consent to the use of analytics cookies.

6862:HKEXHaidilao International Holding Ltd. Analysis

Data as of 2026-05-20 - not real-time

HK$14.27

Latest Price

6/10Risk

Risk Level: Medium

Executive Summary

Haidilao is trading at HK$14.27, barely above its 20‑day SMA (HK$14.59) and just above a key support level around HK$13.82, while the 50‑day SMA remains higher at HK$15.09, suggesting limited upside momentum. Technical indicators show a bearish MACD crossover and a neutral RSI at 42, indicating neither strong oversold nor overbought conditions, but the recent increase in trading volume points to heightened market interest. Fundamentally, the company delivers robust profitability with a 39.6% ROE and a 9.4% profit margin, yet its price‑to‑book (6.9×) and price‑to‑earnings (16.6×) sit above peers, and the DCF‑derived fair value of HK$12.59 implies the stock is currently overvalued. The dividend yield is attractive at 5.07%, but a payout ratio exceeding 100% raises concerns about sustainability. Combined with a high 30‑day volatility of 36% and a low beta (~0.4), the stock presents a mixed risk profile amid a consumer‑cyclical sector sensitive to discretionary spending and regulatory scrutiny in China.
Given the overvaluation relative to intrinsic estimates, the strained dividend payout, and bearish short‑term technical signals, investors may consider a cautious stance. However, Haidilao’s strong cash generation, high ROE, and brand equity support a longer‑term view that could justify accumulation if the price corrects toward its fair value.

Market Outlook

Short Term

< 1 year
Cautious
Model confidence: 7/10

Key Factors

  • Price hovering just above support with bearish MACD
  • Overvaluation relative to DCF fair value
  • High dividend payout ratio (>100%) questioning sustainability

Medium Term

1–3 years
Neutral
Model confidence: 6/10

Key Factors

  • Strong ROE and cash flow generation
  • Elevated valuation multiples but improving earnings outlook
  • Continued exposure to consumer‑cyclical demand cycles

Long Term

> 3 years
Positive
Model confidence: 8/10

Key Factors

  • High return on equity and solid free cash flow
  • Brand strength and franchise expansion potential
  • Opportunity for price correction toward intrinsic value

Key Metrics & Analysis

Financial Health

Revenue Growth5.90%
Profit Margin9.37%
P/E Ratio16.6
ROE39.58%
ROA14.61%
Debt/Equity59.31
P/B Ratio6.9
Op. Cash FlowHK$5.7B
Free Cash FlowHK$3.9B

Technical Analysis

TrendNeutral
RSI42.5
SupportHK$13.82
ResistanceHK$15.54
MA 20HK$14.59
MA 50HK$15.09
MA 200HK$14.51
MACDBearish
VolumeIncreasing
Fear & Greed Index90.25

Valuation

Fair ValueHK$12.59
Target PriceHK$17.80
Upside/Downside24.73%
GradeOvervalued
TypeBlend
Dividend Yield5.07%

Risk Assessment

Beta0.39
Volatility36.07%
Sector RiskMedium
Reg. RiskMedium
Geo RiskMedium
Currency RiskMedium
Liquidity RiskLow

This analysis may contain inaccuracies and is provided for informational and research purposes only. It is not personal investment advice, a recommendation, or an instruction to buy, sell, or hold any asset.